Recent Advances in Glycyrrhetinic Acid-Functionalized Biomaterials for Liver Cancer-Targeting Therapy
Liver cancer is one of the most common causes of cancer mortality worldwide. Chemotherapy and radiotherapy are the conventional therapies generally employed in patients with liver tumors. The major issue associated with the administration of chemotherapeutics is their high toxicity and lack of selec...
Main Authors: | Antonio Speciale, Claudia Muscarà, Maria Sofia Molonia, Mariateresa Cristani, Francesco Cimino, Antonella Saija |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/6/1775 |
Similar Items
-
Glycyrrhizic Acid and Its Hydrolyzed Metabolite 18β-Glycyrrhetinic Acid as Specific Ligands for Targeting Nanosystems in the Treatment of Liver Cancer
by: Luciano A. Stecanella, et al.
Published: (2021-10-01) -
Development of Glycyrrhetinic Acid and Folate Modified Cantharidin Loaded Solid Lipid Nanoparticles for Targeting Hepatocellular Carcinoma
by: Yilin Xu, et al.
Published: (2022-10-01) -
Glycyrrhetinic Acid Receptor-Mediated Zeolitic Imidazolate Framework-8 Loaded Doxorubicin as a Nanotherapeutic System for Liver Cancer Treatment
by: Xiao Mi, et al.
Published: (2023-12-01) -
Glycyrrhetinic Acid Liposomes Containing Mannose-Diester Lauric Diacid-Cholesterol Conjugate Synthesized by Lipase-Catalytic Acylation for Liver-Specific Delivery
by: Jing Chen, et al.
Published: (2017-09-01) -
Hepatic targeting of glycyrrhetinic acid via nanomicelles based on stearic acid-modified fenugreek gum
by: Minghui Zhou, et al.
Published: (2020-01-01)